In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
| Company | Holding % |
|---|---|
| Eli Lilly and Co | 11.99% |
| Johnson & Johnson | 8.83% |
| AbbVie Inc | 8.09% |
| UnitedHealth Group Inc | 6.18% |
| Abbott Laboratories | 4.61% |
| Merck & Co Inc | 4.14% |
| Thermo Fisher Scientific Inc | 3.62% |
| Intuitive Surgical Inc | 3.17% |
| Amgen Inc | 3.00% |
| Pfizer Inc | 2.86% |
| Sector | Weight |
|---|---|
| Healthcare | 100.00% |